The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
Open accessAbstract
The epithelial and endothelial barriers of the human body are major obstacles for drug delivery to the systemic circulation and to organs with unique environment and homeostasis, like the central nervous system. Several transport routes exist in these barriers, which potentially can be exploited for enhancing drug permeability. Beside the transcellular pathways via transporters, adsorptive and receptor-mediated transcytosis, the paracellular flux for cells and molecules is very limited. While lipophilic molecules can diffuse across the cellular plasma membranes, the junctional complexes restrict or completely block the free passage of hydrophilic molecules through the paracellular clefts. Absorption or permeability enhancers developed in the last 40 years for modifying intercellular junctions and paracellular permeability have unspecific mode of action and the effective and toxic doses are very close. Recent advances in barrier research led to the discovery of an increasing number of integral membrane, adaptor, regulator and signalling proteins in tight and adherens junctions. New tight junction modulators are under development, which can directly target tight or adherens junction proteins, the signalling pathways regulating junctional function, or tight junction associated lipid raft microdomains. Modulators acting directly on tight junctions include peptides derived from zonula occludens toxin, or Clostridium perfringens enterotoxin, peptides selected by phage display that bind to integral membrane tight junction proteins, and lipid modulators. They can reversibly increase paracellular transport and drug delivery with less toxicity than previous absorption enhancers, and have a potential to be used as pharmaceutical excipients to improve drug delivery across epithelial barriers and the blood-brain barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Occludin: a novel integral membrane protein localizing at tight junctions.
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1777 · Cited by 2,580
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
Hartsock, A., & Nelson, W. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.012 · Cited by 1,559
Claudin-based tight junctions are crucial for the mammalian epidermal barrier
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., & Tsukita, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110122 · Cited by 1,512
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Complex Phenotype of Mice Lacking Occludin, a Component of Tight Junction Strands
Saitou, M., Furuse, M., Sasaki, H., Schulzke, J.-D., Fromm, M., Takano, H., Noda, T., & Tsukita, S. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4131 · Cited by 1,195
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Astrocyte-endothelial Interactions and Blood-Brain Barrier Permeability*
Abbott, N. J. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00064.x · Cited by 1,168
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Cadherins in development: cell adhesion, sorting, and tissue morphogenesis
Halbleib, J. M., & Nelson, W. J. (2006) · Genes & Development · doi:10.1101/gad.1486806 · Cited by 1,064
Gavard, J., & Gutkind, J. S. (2006) · Nature Cell Biology · doi:10.1038/ncb1486 · Cited by 1,018
Morita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869
Structure and function of claudins
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., & Blasig, I. E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.10.018 · Cited by 829
Umeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823
Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells
Ikenouchi, J., Furuse, M., Furuse, K., Sasaki, H., Tsukita, S., & Tsukita, S. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200510043 · Cited by 787
Crosstalk of tight junction components with signaling pathways
González-Mariscal, L., Tapia, R., & Chamorro, D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.018 · Cited by 759
Tight junctions/adherens junctions: basic structure and function
Niessen, C. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700865 · Cited by 756
Transdermal drug delivery: overcoming the skin’s barrier function
Naik, A., Kalia, Y. N., & Guy, R. H. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00295-9 · Cited by 720
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Microemulsions as transdermal drug delivery vehicles
Kogan, A., & Garti, N. (2006) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2006.05.014 · Cited by 680
Occludin is a functional component of the tight junction
McCarthy, K. M., Skare, I. B., Stankewich, M. C., Furuse, M., Tsukita, S., Rogers, R. A., Lynch, R. D., & Schneeberger, E. E. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.9.2287 · Cited by 645
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604318103 · Cited by 645
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643
Self-citationModelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618
Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands
Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.195 · Cited by 610
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., & Artursson, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012160102740 · Cited by 586
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. M., & Kaper, J. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5242 · Cited by 579
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 547
Treat, L. H., McDannold, N., Vykhodtseva, N., Zhang, Y., Tam, K., & Hynynen, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22732 · Cited by 545
Wong, V., & Gumbiner, B. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.2.399 · Cited by 539
The cadherin-catenin adhesion system in signaling and cancer
Conacci-Sorrell, M., Zhurinsky, J., & Ben-Ze’ev, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15429 · Cited by 532
Konrad, M., Schaller, A., Seelow, D., Pandey, A. V., Waldegger, S., Lesslauer, A., Vitzthum, H., Suzuki, Y., Luk, J. M., Becker, C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508617 · Cited by 528
E‐cadherin is essential for in vivo epidermal barrier function by regulating tight junctions
Tunggal, J. A., Helfrich, I., Schmitz, A., Schwarz, H., Günzel, D., Fromm, M., Kemler, R., Krieg, T., & Niessen, C. M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600605 · Cited by 491 · cited 2×
“Loss of E-cadherin in the epidermis, by conditionally inactivating its gene in mice, results in perinatal death due to the inability to retain a functional epidermal water barrier [47].”
BackgroundStrategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474
Human zonulin, a potential modulator of intestinal tight junctions
Wang, W., Uzzau, S., Goldblum, S. E., & Fasano, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4435 · Cited by 470
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Transmembrane proteins of tight junctions
Chiba, H., Osanai, M., Murata, M., Kojima, T., & Sawada, N. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.017 · Cited by 464
The cadherin-catenin adhesion system in signaling and cancer
Conacci-Sorrell, M., Zhurinsky, J., & Ben-Ze’ev, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215429 · Cited by 464
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Tight junctions are membrane microdomains
Nusrat, A., Parkos, C. A., Verkade, P., Foley, C. S., Liang, T. W., Innis-Whitehouse, W., Eastburn, K. K., & Madara, J. L. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1771 · Cited by 429
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
Muldoon, L. L., Soussain, C., Jahnke, K., Johanson, C., Siegal, T., Smith, Q. R., Hall, W. A., Hynynen, K., Senter, P. D., Peereboom, D. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9861 · Cited by 417
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Expression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347
Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., & Goldblum, S. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118114 · Cited by 342
Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.112 · Cited by 337
Lindmark, T., Kimura, Y., & Artursson, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333
Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., & Sheikov, N. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.105.3.445 · Cited by 314
Watts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not, T., Zielke, R., & Fasano, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500178102 · Cited by 313
Hirase, T., Kawashima, S., Wong, E. Y. M., Ueyama, T., Rikitake, Y., Tsukita, S., Yokoyama, M., & Staddon, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007136200 · Cited by 311
Effects of Cyclodextrins on Drug Delivery Through Biological Membranes
Loftsson, T., Vogensen, S. B., Brewster, M. E., & Konráðsdóttir, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20992 · Cited by 302
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
Tricellulin is a tight-junction protein necessary for hearing
Riazuddin, S., Ahmed, Z. M., Fanning, A. S., Lagziel, A., Kitajiri, S.-I., Ramzan, K., Khan, S. N., Chattaraj, P., Friedman, P. L., Anderson, J. M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/510022 · Cited by 283
Fujita, K., Katahira, J., Horiguchi, Y., Sonoda, N., Furuse, M., & Tsukita, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01744-0 · Cited by 283
Fink, M. P., & Delude, R. L. (2005) · Critical Care Clinics · doi:10.1016/j.ccc.2005.01.005 · Cited by 280
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Absorption Enhancers for Nasal Drug Delivery
Davis, S. S., & Illum, L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00003 · Cited by 264
Functional analysis of tight junctions
Matter, K., & Balda, M. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00029-x · Cited by 264
Nagasawa, K., Chiba, H., Fujita, H., Kojima, T., Saito, T., Endo, T., & Sawada, N. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20647 · Cited by 255
ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability
Wegmann, F., Petri, B., Khandoga, A. G., Moser, C., Khandoga, A., Volkery, S., Li, H., Nasdala, I., Brandau, O., Fässler, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060565 · Cited by 250
Ranaldi, G., Marigliano, I., Vespignani, I., Perozzi, G., & Sambuy, Y. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(01)00208-x · Cited by 230
Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1.
Herbert, C. A., King, C. M., Ring, P. C., Holgate, S. T., Stewart, G. A., Thompson, P. J., & Robinson, C. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.4.7695916 · Cited by 228
Enhancing paracellular permeability by modulating epithelial tight junctions
Ward, P. D., Tippin, T. K., & Thakker, D. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00302-3 · Cited by 227
Bruewer, M., Hopkins, A. M., Hobert, M. E., Nusrat, A., & Madara, J. L. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00087.2004 · Cited by 223
Anderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221
Listeria monocytogenes Invades the Epithelial Junctions at Sites of Cell Extrusion
Pentecost, M., Otto, G., Theriot, J. A., & Amieva, M. R. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020003 · Cited by 220
Megaintestine in Claudin-15–Deficient Mice
Tamura, A., Kitano, Y., Hata, M., Katsuno, T., Moriwaki, K., Sasaki, H., Hayashi, H., Suzuki, Y., Noda, T., Furuse, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.040 · Cited by 220
Han, X., Fink, M. P., Yang, R., & Delude, R. L. (2004) · Shock · doi:10.1097/01.shk.0000112346.38599.10 · Cited by 214
Anderberg, E. K., Nyström, C., & Artursson, P. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810908 · Cited by 214
Wolburg, H., Wolburg-Buchholz, K., Liebner, S., & Engelhardt, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01927-9 · Cited by 210
Zonula Occludens Toxin Structure-Function Analysis
Di Pierro, M., Lu, R., Uzzau, S., Wang, W., Margaretten, K., Pazzani, C., Maimone, F., & Fasano, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009674200 · Cited by 206
Buccal penetration enhancers—How do they really work?
Nicolazzo, J. A., Reed, B. L., & Finnin, B. C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.024 · Cited by 202
Lindmark, T., Nikkilä, T., & Artursson, P. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12150-2 · Cited by 200
Nectin-4 is a new histological and serological tumor associated marker for breast cancer
Fabre-Lafay, S., Monville, F., Garrido-Urbani, S., Berruyer-Pouyet, C., Ginestier, C., Reymond, N., Finetti, P., Sauvan, R., Adélaïde, J., Geneix, J., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-73 · Cited by 197
Wan, Winton, Soeller, Gruenert, Thompson, Cannell, Stewart, Garrod, & Robinson (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00820.x · Cited by 189
Cloning of an Immunoglobulin Family Adhesion Molecule Selectively Expressed by Endothelial Cells
Hirata, K.-I., Ishida, T., Penta, K., Rezaee, M., Yang, E., Wohlgemuth, J., & Quertermous, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100630200 · Cited by 186
Masaoka, Y., Tanaka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.06.004 · Cited by 177
Lysophosphatidic Acid Increases Tight Junction Permeability in Cultured Brain Endothelial Cells
Schulze, C., Smales, C., Rubin, L. L., & Staddon, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68030991.x · Cited by 175
Tomkins, O., Friedman, O., Ivens, S., Reiffurth, C., Major, S., Dreier, J. P., Heinemann, U., & Friedman, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.006 · Cited by 175
Deli, M. A., Descamps, L., Dehouck, M., Cecchelli, R., Joó, F., Ábrahám, C. S., & Torpier, G. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410602 · Cited by 174
Self-citationMultiphoton Imaging of Ultrasound/Optison Mediated Cerebrovascular Effects in vivo
Raymond, S. B., Skoch, J., Hynynen, K., & Bacskai, B. J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600336 · Cited by 174
Structural organization of the tight junctions
Paris, L., Tonutti, L., Vannini, C., & Bazzoni, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.004 · Cited by 171
Absorption-Enhancing Mechanism of EDTA, Caprate, and Decanoylcarnitine in Caco-2 Cells
Tomita, M., Hayashi, M., & Awazu, S. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9504604 · Cited by 169
Raub, T. J., Kuentzel, S. L., & Sawada, G. A. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90442-b · Cited by 161
Schenkel, A. R., Chew, T. W., & Müller, W. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6403 · Cited by 157
Fischer, S., Wiesnet, M., Renz, D., & Schaper, W. K. A. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.03.002 · Cited by 150
Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy
Rapoport, S. I. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1809 · Cited by 147
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G., & Schipper, N. G. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015896405389 · Cited by 146
Increasing Epithelial Junction Permeability Enhances Gene Transfer to Airway Epithelia In Vivo
Wang, G., Zabner, J., Deering, C., Launspach, J. L., Shao, J., Bodner, M., Jolly, D. J., Davidson, B. L., & McCray, P. B. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.2.3938 · Cited by 143
A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator
Kondoh, M., Masuyama, A., Takahashi, A., Asano, N., Mizuguchi, H., Koizumi, N., Fujii, M., Hayakawa, T., Horiguchi, Y., & Watanbe, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.008375 · Cited by 143
Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7
Sanovich, E. Y., Bartus, R. T., Friden, P. M., Dean, R. L., Le, H. Q., & Brightman, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01143-9 · Cited by 142
Borlongan, C. V., & Emerich, D. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00043-1 · Cited by 142
Enhanced Prospects for Drug Delivery and Brain Targeting by the Choroid Plexus–CSF Route
Johanson, C. E., Duncan, J. A., Stopa, E. G., & Baird, A. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6039-0 · Cited by 139
Lipschutz, J. H., Li, S., Arisco, A. M., & Balkovetz, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408122200 · Cited by 139
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption
Smith, J. M., Dornish, M., & Wood, E. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.020 · Cited by 138
Effects of Some Non-ionic Surfactants on Transepithelial Permeability in Caco-2 Cells
Dimitrijević, D., Shaw, A. J., & Florence, A. T. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773805 · Cited by 137
Regulation of Blood-Brain Tumor Barrier Permeability by Calcium-Activated Potassium Channels
Ningaraj, N. S., Rao, M. K., Hashizume, K., Asotra, K., & Black, K. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.838 · Cited by 130
Dejana, E., Lampugnani, M. G., Martínez-Estrada, O. M., & Bazzoni, G. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11061439 · Cited by 125
Charge-related alterations of the cerebral endothelium.
Nagy, Z., Peters, H. C., & Hüttner, I. (1983) · PubMed · Cited by 124
Warren, K. E., Jakacki, R. I., Widemann, B. C., Aikin, A. A., Libucha, M., Packer, R. J., Vézina, G., Reaman, G. H., Shaw, D., Krailo, M., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0172-7 · Cited by 123
Lippoldt, A., Liebner, S., Andbjer, B., Kalbacher, H., Wolburg, H., Haller, H. G., & Fuxé, K. (2000) · Neuroreport · doi:10.1097/00001756-200005150-00015 · Cited by 123
András, I. E., Pu, H., Tian, J., Deli, M. A., Nath, A., Hennig, B., & Toborek, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600115 · Cited by 121
Self-citationEmerich, D. F., Dean, R. L., Osborn, C., & Bartus, R. T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140020-00003 · Cited by 119
Roles and modes of action of nectins in cell–cell adhesion
Irie, K., Shimizu, K., Sakisaka, T., Ikeda, W., & Takai, Y. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.09.002 · Cited by 115
Ishihara, H., Kubota, H., Lindberg, R. L. P., Leppert, D., Gloor, S. M., Errede, M., Virgintino, D., Fontana, A., Yonekawa, Y., & Frei, K. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816fd622 · Cited by 114
Francis, S. A., Kelly, J. M., McCormack, J. M., Rogers, R. A., Lai, J., Schneeberger, E. E., & Lynch, R. D. (1999) · European Journal of Cell Biology · doi:10.1016/s0171-9335(99)80074-0 · Cited by 114
A New Principle for Tight Junction Modulation Based on Occludin Peptides
Tavelin, S., Hashimoto, K., Malkinson, J. P., Lazorova, L., Tóth, I., & Artursson, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1530 · Cited by 114
El-Bachá, R. D. S., & Minn, A. (1999) · PubMed · Cited by 114
Lacaz-Vieira, F., Jaeger, M. M. M., Farshori, P., & Kachar, B. (1999) · The Journal of Membrane Biology · doi:10.1007/s002329900518 · Cited by 112
Erdlenbruch, B., Alipour, M., Fricker, G., Miller, D. S., Kugler, W., Eibl, H., & Lakomek, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705554 · Cited by 109
Enhanced Epithelial Gene Transfer by Modulation of Tight Junctions with Sodium Caprate
Coyne, C. B., Kelly, M. M., Boucher, R. C., & Johnson, L. G. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.5.4164 · Cited by 106
Lindmark, T., Söderholm, J. D., Olaison, G., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012112219578 · Cited by 105
Adrenomedullin regulates blood–brain barrier functions in vitro
Kis, B., Deli, M. A., Kobayashi, H., Ábrahám, C. S., Yanagita, T., Kaiya, H., Isse, T., Nishi, R., Gotoh, S., Kangawa, K., et al. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00055 · Cited by 99
Self-citationGardner, T. W., Lesher, T., Khin, S. A., Cuong, V. U., Barber, A. J., & Brennan, W. A. (1996) · Biochemical Journal · doi:10.1042/bj3200717 · Cited by 98
Stimulus-induced reorganization of tight junction structure: The role of membrane traffic
Yu, D., & Turner, J. R. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.027 · Cited by 97
In vitro toxicity and permeation of cyclodextrins in Calu-3 cells
Matilainen, L., Toropainen, T., Vihola, H., Hirvonen, J. J., Järvinen, T., Jarho, P., & Järvinen, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.003 · Cited by 95
Chiu, T. T., & Rozengurt, E. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c929 · Cited by 95
Lin, H., Gebhardt, M., Bian, S., Kwon, K. A., Shim, C., Chung, S.-J., & Kim, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.043 · Cited by 92
Strazielle, N., Khuth, S. T., & Ghersi‐Egea, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.006 · Cited by 90
Dharmsathaphorn, K., Huott, P. A., Vongkovit, P., Beuerlein, G., Pandol, S. J., & Ammon, H. V. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114257 · Cited by 87
Adrenomedullin Improves the Blood–Brain Barrier Function Through the Expression of Claudin-5
Honda, M., Nakagawa, S., Hayashi, K., Kitagawa, N., Tsutsumi, K., Nagata, I., & Niwa, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9028-x · Cited by 87
Lindmark, T., Schipper, N. G. M., Lazorova, L., Boer, A. G. D., & Artursson, P. (1998) · Journal of drug targeting · doi:10.3109/10611869808995876 · Cited by 86
Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat
Wolburg, H., Wolburg‐Buchholz, K., Sam, H., Horvát, S., Deli, M. A., & Mack, A. F. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0410-2 · Cited by 85
Self-citationShao, Z., Li, Y., Chermak, T., & Mitra, A. K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018997101542 · Cited by 83
Corneal Organ Culture Model for Assessing Epithelial Responses to Surfactants
Xu, K. (2000) · Toxicological Sciences · doi:10.1093/toxsci/58.2.306 · Cited by 80
Nitz, T., Eisenblaetter, T., Psathaki, K., & Galla, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02834-8 · Cited by 79
Karyekar, C. S., Fasano, A., Raje, S. V., Lu, R., Dowling, T. C., & Eddington, N. D. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10310 · Cited by 79
Haselbach, M., Wegener, J., Decker, S., Engelbertz, C. M., & Galla, H. (2000) · Microscopy Research and Technique · Cited by 79
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
Yang, T., Hussain, A., Paulson, J. R., Abbruscato, T. J., & Ahsan, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032998.84488.7a · Cited by 77
Doctrow, S. R., Abelleira, S. M., Curry, L., Heller-Harrison, R. A., Kozarich, J. W., Malfroy, B., McCarroll, L. A., Morgan, K. G., Morrow, A. R., & Musso, G. F. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22763-x · Cited by 76
Eibl, H., Jendrossek, V., Erdlenbruch, B., & Lakomek, M. (2000) · Experimental Brain Research · doi:10.1007/s002210000553 · Cited by 75
Mullin, J. M., Laughlin, K. V., Ginanni, N., Marano, C. W., Clarke, H., & Soler, A. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05246.x · Cited by 75
Lambert, D., O’Neill, C. A., & Padfield, P. J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000107533 · Cited by 74
Takahashi, A., Kondoh, M., Masuyama, A., Fujii, M., Mizuguchi, H., Horiguchi, Y., & Watanabe, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.008 · Cited by 73
Greenwood, J., Adu, J., DAVEY, A. J., Abbott, N. J., & Bradbury, M. W. B. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.116 · Cited by 71
Specific AHNAK expression in brain endothelial cells with barrier properties
Gentil, B. J., Benaud, C. M., Delphin, C., Remy, C. C., Bérézowski, V., Cecchelli, R., Feraud, O., Vittet, D., & Baudier, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20232 · Cited by 70
In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
Hochman, J. H., Fix, J. A., & LeCluyse, E. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38767-7 · Cited by 70
Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels.
VORBRODT, A. W., & Dobrogowska, D. H. (2004) · PubMed · doi:10.5603/4660 · Cited by 69
Advances in nasal drug delivery through tight junction technology
Johnson, P. H., & Quay, S. C. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.281 · Cited by 68
Flt‐1, but not Flk‐1 mediates hyperpermeability through activation of the PI3‐K/Akt pathway
Vogel, C., Bauer, A. T., Wiesnet, M., Preissner, K. T., Schaper, W. K. A., Marti, H. H., & Fischer, S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21022 · Cited by 67
Lu, R., Wang, W., Uzzau, S., Vigorito, R. D., Zielke, H. R., & Fasano, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740320.x · Cited by 67
Sinaga, E., Jois, S. D. S., Avery, M., Makagiansar, I. T., Tambunan, U. S. F., Audus, K. L., & Siahaan, T. J. (2002) · Pharmaceutical Research · doi:10.1023/a:1019850226631 · Cited by 66
Duizer, E., Wulp, C. V. D., Versantvoort, C. H. M., & Groten, J. P. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37802-4 · Cited by 66
Aspenström-Fagerlund, B., Ring, L., Aspenström, P., Tallkvist, J., Ilbäck, N., & Glynn, A. W. (2007) · Toxicology · doi:10.1016/j.tox.2007.04.014 · Cited by 62
A Novel Strategy for a Drug Delivery System Using a Claudin Modulator
Kondoh, M., Takahashi, A., Fujii, M., Yagi, K., & Watanabe, Y. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1783 · Cited by 62
Erdlenbruch, B., Schinkhof, C., Kugler, W., Heinemann, D. E. H., Herms, J. W., Eibl, H., & Lakomek, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705302 · Cited by 62
Vascular microenvironment in gliomas
Vajkoczy, P., & Menger, M. D. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_15 · Cited by 62
Cox, D. S., Raje, S. V., Gao, H., Salama, N. N., & Eddington, N. D. (2002) · Pharmaceutical Research · doi:10.1023/a:1020709513562 · Cited by 61
Fetih, G. N., Habib, F., Okada, N., Fujita, T., Attia, M., & Yamamoto, A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.017 · Cited by 61
Yamamoto, A., Tatsumi, H., Maruyama, M., Uchiyama, T., Okada, N., & Fujita, T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29666-x · Cited by 61
Söderholm, J. D., Öman, H., Blomquist, L., Veen, J., Lindmark, T., & Olaison, G. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018823100761 · Cited by 60
Pharmacological blood-brain barrier modification for selective drug delivery
Cloughesy, T. F., & Black, K. L. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060218 · Cited by 60
Nitric Oxide Redox Species Exert Differential Permeability Effects on the Blood-Brain Barrier
Boje, K. M. K., & Lakhman, S. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39267-5 · Cited by 59
Modulation of cellular adhesion in bovine brain microvessel endothelial cells by a decapeptide
Pal, D., Audus, K. L., & Siahaan, T. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01223-1 · Cited by 56
Dobrogowska, D. H., & VORBRODT, A. W. (2004) · The Histochemical Journal · doi:10.1007/10.1007/s10735-004-1318-3 · Cited by 55
Nitric Oxide Donors Enhance Rectal Absorption of Macromolecules in Rabbits
Utoguchi, N., Watanabe, Y., Shida, T., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011920530771 · Cited by 54
Lambìase, A., Pagani, L., Fausto, V. D., Sposato, V., Coassin, M., Bonini, S., & Aloe, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.102 · Cited by 54
SONG, K., FASANO, A., & Eddington, N. D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.011 · Cited by 53
Oleic acid reversibly opens the blood-brain barrier
Sztriha, L. ́. ́., & Betz, A. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)91326-v · Cited by 53
Monnaert, V., Betbeder, D., Fénart, L., Bricout, H., Lenfant, A., Landry, C., Cecchelli, R., Monflier, É., & Tilloy, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071845 · Cited by 53
Westergren, I., & Johansson, B. B. (1993) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1993.tb09597.x · Cited by 52
Signalling pathways regulating the tight junction permeability in the blood-brain barrier.
Krizbai, I. A., & Deli, M. A. (2003) · PubMed · Cited by 52
Self-citationSaija, A., Princi, P., Trombetta, D., Lanza, M., & Pasquale, A. D. (1997) · Experimental Brain Research · doi:10.1007/pl00005725 · Cited by 51
Cdc42 Regulates the Restoration of Endothelial Adherens Junctions and Permeability
Broman, M., Mehta, D., & Malik, A. B. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.03.004 · Cited by 51
Lippoldt, A., Jansson, A., Kniesel, U., Andbjer, B., Andersson, A. K., Wolburg, H., Fuxé, K., & Haller, H. G. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02355-0 · Cited by 51
Cox, D. S. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00172-2 · Cited by 50
Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-κB
Park, J., Kim, Y., Song, H. S., Park, K. Y., Kim, Y. M., Kim, M., Pak, Y. K., Lee, I. K., Lee, J. D., Park, S., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00436-4 · Cited by 50
Marinaro, M., Fasano, A., & Magistris, M. T. D. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1897-1902.2003 · Cited by 50
Chen, S., Eiting, K. T., Cui, K., et al. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20510 · Cited by 48
Targeting tight junction proteins-significance for drug development
Kondoh, M., Yoshida, T., Kakutani, H., & Yagi, K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.005 · Cited by 47
Cadherin-10 is a novel blood–brain barrier adhesion molecule in human and mouse
Williams, M. J., Lowrie, M. B., Bennett, J. P., Firth, J. A., & Clark, P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.078 · Cited by 47
Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120
Langford, D., Rosemary, H., Hashimoto, M., Digicaylioglu, M. H., & Masliah, E. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-8 · Cited by 46
Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice
Yao, J., Zhou, J., Ping, Q. N., Lu, Y., & Chen, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.010 · Cited by 46
Deli, M. A., Dehouck, M., Abraham, C., Cecchelli, R., & Joó, F. (1995) · Experimental Physiology · doi:10.1113/expphysiol.1995.sp003877 · Cited by 45
Self-citationNotman, R., Noro, M. G., & Anwar, J. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp0723564 · Cited by 45
Pardridge, W. M. (2007) · Stroke · doi:10.1161/01.str.0000247887.61831.74 · Cited by 45
The Impact of ΔG on the Oral Bioavailability of Low Bioavailable Therapeutic Agents
Salama, N. N., Fasano, A., Thakar, M., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073205 · Cited by 45
Song, K., Fasano, A., & Eddington, N. D. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.011 · Cited by 44
PECAM‐1 engagement counteracts ICAM‐1‐induced signaling in brain vascular endothelial cells2
Couty, J., Rampon, C., Leveque, M., Laran‐Chich, M., Bourdoulous, S., Greenwood, J., & Couraud, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04782.x · Cited by 42
Targeted Drug Delivery to the Brain Using Focused Ultrasound
Kinoshita, M. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3180332e79 · Cited by 42
Farkas, A. E., Szatmari, E. M., Orbók, A., Wilhelm, I., Wejksza, K., Nagyőszi, P., Hutamekalin, P., Bauer, H., Bauer, H., Traweger, A., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20521 · Cited by 42
3Alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator.
Mikov, M., Kevrešan, S., Kuhajda, K., Jakovljević, V., & Vasović, V. (2004) · PubMed · Cited by 42
Everett, R., Vanhook, M. K., Barozzi, N., Tóth, I., & Johnson, L. G. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017251 · Cited by 41
Sun, Z., Olanders, K. J., Lasson, Å., Dib, M., Annborn, M., Andersson, K., Wang, X., & Andersson, R. E. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2001.6342 · Cited by 39
Discovery of tight junction modulators: significance for drug development and delivery
Johnson, P. H., Frank, D. E., & Costantino, H. R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.023 · Cited by 38
González‐Mariscal, L., & Nava, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.004 · Cited by 38
Mačkić, J. B., Stins, M. F., Jovanovic, S. S., Kim, K. S., Bartus, R. T., & Zloković, B. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018938722768 · Cited by 37
An Inhibitory Role of Nitric Oxide in the Dynamic Regulation of the Blood-Brain Barrier Function
Yamauchi, A., Dohgu, S., Nishioku, T., et al. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9139-z · Cited by 35
LeCluyse, E. L., Sutton, S. C., & Fix, J. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38218-2 · Cited by 35
Erdlenbruch, B., Jendrossek, V., Kugler, W., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0497-4 · Cited by 34
Kim, H. J., Pyeun, Y. S., Kim, Y.-W., Cho, B. M., Lee, T. H., Moon, T. Y., Suh, K. T., & Park, B.-R. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000160488.26344.5f · Cited by 33
Alterations in cell cholesterol content modulate Ca2+‐induced tight junction assembly by MDCK cells
Stankewich, M. C., Francis, S. A., Vu, Q., Schneeberger, E. E., & Lynch, R. D. (1996) · Lipids · doi:10.1007/bf02522977 · Cited by 31
Graded reversible opening of the rat blood–brain barrier by intracarotid infusion of sodium caprate
Preston, E., Slinn, J., Vinokourov, I., & Stanimirovic, D. B. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.11.004 · Cited by 27
Masuyama, A., Kondoh, M., Seguchi, H., Takahashi, A., Harada, M., Fujii, M., Mizuguchi, H., Horiguchi, Y., & Watanabe, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085399 · Cited by 26
Phorbol ester induced short- and long-term permeabilization of the blood–CSF barrier in vitro
Angelow, S., Zeni, P., Höhn, B., & Galla, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.058 · Cited by 24
Enhancement of brain distribution of anticancer agents using ΔG, the 12kDa active fragment of ZOT
Menon, D., Karyekar, C. S., Fasano, A., Lu, R., & Eddington, N. D. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.006 · Cited by 23
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Wearable sensors: modalities, challenges, and prospects
Heikenfeld, J., Jajack, A., Rogers, J., Gutruf, P., Tian, L., Pan, T., Li, R., Khine, M., Kim, J., Wang, J., et al. (2018) · Lab on a Chip · doi:10.1039/c7lc00914c · Cited by 1,434
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
M. Ways, T., Lau, W., & Khutoryanskiy, V. (2018) · Polymers · doi:10.3390/polym10030267 · Cited by 908
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Metadata
- Authors
- Deli, M. A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 1788
- Issue
- 4
- Pages
- 892-910
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2096996795
- Cited by
- 385
- References
- 211
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.